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The administration of a high fat content diet is an accelerating factor for metabolic
syndrome, impaired glucose tolerance, and early type 2 diabetes. The present study
aims to assess the impact of a high fat diet on tuberculosis progression and microbiota
composition in an experimental animal model using a C3HeB/FeJ mouse strain
submitted to single or multiple consecutive aerosol infections. These models allowed us
to study the protection induced by Bacillus Calmette-Guérin vaccination as well as by the
natural immunity induced by chemotherapy after a low doseMycobacterium tuberculosis
infection. Our results show that a high fat diet is able to trigger a pro-inflammatory
response, which results in a faster progression toward active tuberculosis and an
impaired protective effect of BCG vaccination, which is not the case for natural immunity.
This may be related to dysbiosis and a reduction in the Firmicutes/Bacteroidetes ratio in
the gut microbiota caused by a decrease in the abundance of the Porphyromonadaceae
family and, in particular, the Barnesiella genus. It should also be noted that a high fat diet
is also related to an increase in the genera Alistipes, Parasuterella, Mucispirillum, and
Akkermansia, which have previously been related to dysbiotic processes. As diabetes
mellitus type 2 is a risk factor for developing tuberculosis, these findings may prove useful
in the search for new prophylactic strategies for this population subset.
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INTRODUCTION
Tuberculosis (TB) is still a major challenge facing humanity in the twenty-first century. Since the
declaration by the World Health Organization of a global emergency 25 years ago, the absolute
number of cases seems to have stabilized. However, the reduction in incidence of around 1.5% is
far from the value of 25% needed to achieve the 2025 objective (1).
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Several factors, including severe immunosuppression (caused
by HIV, immunosuppressive drugs or anti-TNF antibodies),
alcoholism and tobacco smoking, have been reported to increase
the probability of developing TB (2). One of the most important
factors is malnutrition (3, 4). A reduction in body mass index
(BMI) to below 18 has been shown to be a strong risk factor
for TB (5). In several infectious diseases, such as community-
acquired pneumonia, sepsis, Chagas disease, or TB, there are
consistent epidemiological data showing the advantages of
obesity, with negative outcomes being inversely related to BMI.
This benefit can also be seen for a variety of surgical and non-
surgical conditions (6, 7). This means that subjects with better
nutrition, more body fat and highly activated immune functions
are more likely to survive. Metabolic syndrome intensifies with
an increase in adiposity, thereby raising the level of immune
protection, which at the same time is counterbalanced by the
deleterious effects of dysglycemia. This process is known as the
“obesity paradox” (6).
In contrast, it is well-known that diabetes mellitus type 2
(DM2) is also a risk factor for TB (8), although this is also
linked to obesity and, therefore, an increased BMI. This new link
is specially worrying considering the overwhelming increase in
DM2 incidence in high TB burden countries, such as India and
South Africa (9, 10). Obesity, insulin resistance and DM2 are
closely associated with a chronic state of low-grade inflammation
(11). In particular, in obesity there is an over-expression of
TNF-α, which attracts M1 macrophages, thereby increasing the
levels of inflammatory mediators such as C-reactive protein,
IL-1, IL-6, IL-8, IL-12, and IFN-γ. In this sense, DM2 also
results in an increase in neutrophils and monocyte-secreted
cytokines, including TNF-α, IL-6, and IL-8. In addition, there is
an impairment in infection-induced cytokine production and a
reduction in phagocytic and antibacterial activity. DM2 decreases
the level of regulatory T cells (Tregs) while increasing Th17, thus
promoting an exaggerated inflammatory response (12).
A high fat diet (HFD) has been linked to an increased
diversity in the intestinal microbiota, thus providing an anti-
inflammatory milieu (13), and a decrease in the Firmicutes to
Bacteroidetes (F/B) ratio, which has been related to glucose
intolerance (14). In an experimental model of TB using BALB/c
mice, infection induced an initial decrease in microbiota
diversity, which tended to recover with chronification. This
work highlights the significant decrease in Clostridiales (phylum
Firmicutes), as promoters of Tregs, and Bacteroidales (phylum
Bacteroidetes), as inducers of IL-10-producing T cells and
modulators of the Th1/Th2 balance (15). Recent studies of
an experimental model in C57BL/6J-CD45a mice infected
with Mycobacterium tuberculosis (Mtb) demonstrated the rapid
dysbiosis caused by conventional TB chemotherapy, with this
condition persisting for a long time after cessation (16). The
Abbreviations: TB, Tuberculosis; BMI, Body mass index; DM2, Diabetes
mellitus type 2; Tregs, Regulatory T cells; HFD, High fat diet; F/B, Firmicutes
to Bacteroidetes; Mtb, Mycobacterium tuberculosis; BL, Bacillary load; BCG,
Bacillus Calmette-Guérin; SI, Single infection; MCI, Multiple consecutive
infections; NI, Natural immunity; CFU, Colony-forming unit; ND, Normal
diet; p.i., Post-infection; OTU, Operational taxonomic unit; NMDS, Non-metric
multidimensional scaling; MST, Median survival time.
impact of standard treatment (HRZE) in TB patients has also
been assessed, demonstrating a long-lasting microbiota dysbiosis
with a variation in several species of the Firmicutes and
Bacteroidetes phyla (17). Interestingly, both studies showed an
increased abundance of the Erysipelotrichaceae family, which,
in contrast to other Firmicutes, has been linked to a pro-
inflammatory milieu (18). Curiously, a recent study in a human
cohort has shown an increase in the gut microbiota diversity in
TB patients. This is an interesting finding given that the BMI of
TB patients was significantly lower than for healthy controls (19).
The first objective of this study was to evaluate the role of
HFD-induced obesity in the development of TB in an active
TB murine model using the C3HeB/FeJ mouse strain (20) by
assessing the bacillary load (BL), pathology and cytokine profiles
in lungs, survival rates, and gut microbiota content. We also
evaluated the effect of multiple consecutive infections vs. a
single aerosol infection. This is a better way of mimicking the
scenario of household contacts, where subjects are at high risk
of developing TB due to their daily contact with a TB patient
and those persons that live in regions with a high infection risk
(21). In this complex scenario, we tested the influence of Bacillus
Calmette-Guérin (BCG) vaccination and natural infection on
disease progression.
As there is a lack of animal studies regarding the mechanisms
behind the DM2-TB comorbidity, which are key to better
understanding the pathology and improving the management
of the disease, we believe this research represents a significant
contribution to the field by providing an animal model for testing
TB vaccines in a context of obesity and early DM2, an issue
closely related to current society.
MATERIALS AND METHODS
Experimental Design
Two different experiments were planned in order to evaluate: (a)
the effect of HFD-induced obesity on the mouse model of active
TB using the C3HeB/FeJ strain (comorbidity model), as well as
BCG vaccination and two different types of challenge [single
infection or multiple consecutive infections (SI or MCI)]; and
(b) the effect of BCG vaccination compared to natural immunity
(NI) in the same comorbidity model.
Table 1 shows the experimental design of both experiments
and Table 2 the experimental groups and experimental
conditions used.
In the first experiment (n = 240), four groups were
subcutaneously vaccinated with 106 colony-forming units (CFU)
of BCG Live U.S.P vaccine (SII-ONCO-BCG R©); the four
remaining groups were sham vaccinated. After 12 weeks, mice
were challenged with a low dose aerosol to deliver around 50
CFU of M. tuberculosis H37Rv Pasteur strain to the lungs using
an airborne infection apparatus (Glas-col Inc., Terre Haute, IN,
USA). In the case of MCI, this challenge was done by infecting
animals eight times over a period of 5 days. Animals were
euthanized at week 3 (n= 5 per group), week 4 [n= 5 per group,
except for group normal diet (ND) andMCIwith n= 4] andweek
16 (n = 10 per group) post-infection (p.i.). BL and pathology
in lungs were analyzed. Lung samples at week 4 were also used
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TABLE 1 | Experimental design of both experiments performed in the study.
Experimental design
Experiment 1 Time of infection –w12 w0 w3 w4 w16 w16→
Time of diet w0 w12 w15 w16 w28 w28→
BCG Infection Euthanasia (n = 5) Euthanasia (n = 5) Euthanasia (n = 10) Survival (n = 10)
Experiment 2 Time of infection –w12 –w10 to w0 w0 w0→
Time of diet w0 w2 to w10 w12 w12→
Single infection Antibiotic treatment Infection Survival
(n = 10)
Bold values correspond to weeks post and pre-infection.
–w12: 12 weeks before challenge; w3, w4, w16: 3, 4, and 16 weeks post-challenge.
TABLE 2 | Experimental groups and conditions tested per experiment.
Experiment 1 Experiment 2
Group Experimental conditions Group Experimental conditions
Obesity BCG Type of infection Obesity Protection Type of infection
ND-SI No No SI ND-NI NO NI MCI
ND-MCI No No MCI HFD-NI YES NI MCI
ND-BCG-SI No Yes SI
ND-BCG-MCI No Yes MCI
HFD-SI Yes No SI
HFD-MCI Yes No MCI
HFD-BCG-SI Yes Yes SI
HFD-BCG-MCI Yes Yes MCI
to evaluate immune responses. Fecal samples (n = 5 per group)
were obtained at weeks 4 and 16 in order to analyze microbiota
composition. The 10 remaining animals per group were allocated
to assess impact on survival.
In the second experiment, the protective effect of BCG
vaccination in MCI mice obtained from experiment 1 was
compared to NI in MCI animals (n = 30). NI was used
to evaluate the memory-immune response protection after M.
tuberculosis challenge. To evaluate NI, animals were challenged
with a SI of low dose aerosol and animals were left 2 weeks to
develop immunity. Then, animals were treated with isoniazid
and rifapentine (25 and 10 mg/kg, respectively) for 10 weeks
from week 2 p.i., to sterilize lungs. In order to test whether
undetectable BL was achieved, three animals of each group were
euthanized and lung samples were plated. No CFU counts were
detected after 21 days of incubation period (limit of detection
= 10 CFU) (data not shown) as described in previous works
(22–24). Two weeks after stopping antibiotic treatment, animals
were challenged with MCI. Fecal samples (n= 5 per group) were
obtained at week 4 in order to analyze microbiota composition.
Differences in protection were assessed by survival (n = 10
per group).
Animals
Female C3HeB/FeJ specific-pathogen-free mice (6–8 weeks old)
were obtained from Jackson Laboratories (Bar Harbor, Maine,
USA), and all procedures were conducted in a BSL-3 facility.
Animals were maintained on a 12 h light-dark cycle in a
temperature- and humidity-controlled room. Animals from non-
obese experimental groups were fed with ND containing 13%
calories from fat (2014S Teklad Global 14% Protein Rodent
Maintenance Diet, Envigo). Animals from those experimental
groups in which obesity was assessed were fed with an HFD
containing 60.3% calories from fat [TD.06414 Adjusted Calories
Diet (60/Fat), Envigo]. Animal weight was recorded weekly.
Ethics
All procedures were performed according to protocol
DMAH6119, which was reviewed by the Animal
Experimentation Ethics Committee of the Hospital Universitari
Germans Trias i Pujol (registered as B9900005) and approved by
the Departament d’Agricultura, Ramaderia, Pesca, Alimentació
i Medi Natural of the Catalan Regional Government, according
to current national and European Union legislation regarding
the protection of experimental animals. Mice were supervised
daily following a strict monitoring protocol in order to ensure
animal welfare, and euthanized, if required, with isoflurane
(inhalation excess).
Oral Glucose Tolerance Test
Oral glucose tolerance test was performed 11 weeks after diet
feeding. After overnight fasting period, mice were administered
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with 2 g/kg by oral gavage. Blood samples were taken at 0, 15,
30, 60, and 120min and glucose levels were measured with a
glucometer (Accutrend Plus, Roche Diagnostics, Switzerland).
Bacillary Load
Left lung samples from each animal were collected, homogenized
and several dilutions plated on nutrient Middlebrook 7H11 agar
(BD Diagnostics, Spark, USA). Visible CFU were counted after
incubation for 28 days at 37◦C.
Lung Pathology
Right lower lung lobe samples were fixed in 10% buffered
formalin, embedded in paraffin and 5µm sections stained with
hematoxylin-eosin for microscopic observation and analysis of
the damaged area using theNISElements D version 3.0× software
package (Nikon Instruments Inc., Tokyo, Japan). Four recuts of
a block containing all group samples were used to determine the
damaged area as a percentage of total lung area. Moreover, the
proportion of exudative lesions in the total damaged area was
measured to obtain the relative exudative area.
Survival
The effect on survival was evaluated in 10 animals from each
group. Animals were euthanized according to the humanized
end-point protocol approved by the ethics committee.
Cytokine Profile Analysis
A cytokine profile study was performed in lung homogenates
from right upper and middle lobes. The following cytokines
were measured by Luminex xMAP R© technology: IFN-γ, TNF-α,
transforming growth factor beta (TGF-β), IL-2, IL-6, IL-10, IL12,
IL-17, CXCL1, and CXCL5. Results are expressed as pg per ml
of supernatant. The assay was performed with the MILLIPLEX R©
MAP kit (EMD Millipore Corporation, Billerica, MA, USA)
following the manufacturer’s instructions and analyzed with
xPONENT Software (Luminex Corporation, Austin, TX, USA).
Microbiota Analysis
Sample Processing and DNA Extraction
Cecum from the animals was extracted and stored at −80◦C
until DNA extraction. Samples were thawed on ice and stools
separated from the intestinal epithelia. DNA was extracted using
a QIAamp Fast DNA StoolMini Kit (QIAGENGmbH, Germany)
according to the manufacturer’s instructions. Three 4mm glass
beads were added in the first step before vortexing to enhance
cell lysis. The total volume of eluate was stored at −20◦C until
concentration measurement. DNA concentrations of the extracts
were measured fluorometrically using the Qubit dsDNAHS assay
kit (Thermo Fisher Scientifics, Waltham, MA, USA). DNA was
stored at−20◦C until 16s rRNA gene library preparation.
16S rRNA Gene Sequencing
Microbial DNA was analyzed using the Illumina 16S
Metagenomic Sequencing Library Preparation guide, with
some modifications. The protocol targets the V3–V4 regions of
the 16S rRNA gene, which were amplified using the KAPA HiFi
HotStart PCR Kit (KAPA Byosystems, Wilmington, MA, USA).
The composition of a typical PCR was as follows: 1X KAPA
HiFi Fidelity Buffer, 0.5mM MgCl2, 0.3mM KAPA dNTP Mix,
0.3µM primers, 0.5U KAPA HiFi HotStart DNA Polymerase,
and 15 ng DNA template. The PCR program with Mastercycler
pro (Eppendorf, Hamburg, Germany) consisted of the following
steps: initial denaturation at 95◦C for 3min, 18 cycles at 95◦C
for 30 s, 55◦C for 30 s, and 72◦C for 30 s, and a final extension
at 72◦C for 4min. The expected product size was ∼550 bp.
The PCR products were purified using Agencourt AMPure XP
magnetic beads (Beckman Coulter, Brea, CA) using a Magnetic
Stand-96 (Thermo Fisher Scientific). The PCR products were
quality controlled with a 1.4% Agarose Gel. The Index PCR
was performed using Nextera XT DNA Library Preparation
Kit (Illumina) and KAPA HiFi HotStart PCR Kit as follows:
1X KAPA HiFi Fidelity Buffer, 0.5mM MgCl2, 0.3mM KAPA
dNTP Mix, 0.3µM primers, 0.5U KAPA HiFi HotStart DNA
Polymerase, and 5 µL of Nextera XT Index 1 Primers and
Nextera XT Index 2 Primers per sample. The procedure was
performed as described in the 16S Metagenomic Sequencing
Library Preparation guide. Library products were purified as
PCR products. The final DNA concentrations of the purified
products were measured using a Qubit 3.0 fluorimeter (Thermo
Fisher Scientific) and validated with the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). The purified
products were diluted to a final concentration of 4 nM and
pooled. The pool was denatured and sample loaded, as per the
16S Metagenomic Sequencing Library Preparation guide, at a
final concentration of 7 p.m. The 16S rRNA gene libraries were
sequenced with 2 × 300 paired-end reads using the Illumina
MySeq system (Illumina).
Statistics, Sequence Processing and Bioinformatics
Data Analysis
The non-parametric Mann–Whitney test was used to make
comparisons between groups using Graphpad Prism (GraphPad
software v6.0, La Jolla, California, USA). Survival curves were
created using the product limit method of Kaplan and Meier
and were compared using the log-rank test. Body weight increase
slopes were compared using linear regression test. Statistically
significant differences are designated as follows: ∗p < 0.05; ∗∗p
< 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
Immune Response Analysis
A three-way ANOVA was used to assess the effect of diet,
infection and BCG vaccination on the immune response in
lungs. A logarithmic transformation was applied to normalize the
cytokine concentrations. In order to obtain equally sized samples,
the missing value in the ND-MCI group was replaced by the
mean for the group. Holm–Sidak multiple comparisons were
performed using the means of groups differing in only one factor.
Plotting and statistical analysis were carried out using Graphpad
Prism (GraphPad software v7.0, La Jolla, California, USA).
The immune response in lungs was also analyzed by Principal
Component Analysis (PCA) using RStudio (version 1.1.463).
PC1 and PC2 represent the two principal components that
contribute to most of the variance. The direction of the arrows
and their lengths represent the contribution and strength of each
principal component. Cytokine concentration levels were scaled
to unit variance.
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FIGURE 1 | Weight evolution during the experiment in pre- and post-infection status. Weight evolution of the same experiment is represented by comparing ND and
HFD (A–F) and Sham and BCG (G–L). Panels represent: pre-infection and sham (A), SI and sham (B), MCI and sham (C), pre-infection and BCG (D), SI and BCG
(E), MCI and BCG (F), pre-infection and ND (G), SI and ND (H), MCI and ND (I), pre-infection and HFD (J), SI and HFD (K), MCI and HFD (L). Linear regression are
represented together with p-values. Slopes’ values are included in Table S1.
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Bacterial Diversity Analysis
The resulting read files were analyzed using mothur pipeline
(version 1.39.5). Paired-end reads were joined and quality
controlled. Sequences were aligned using the SILVA reference
database. Those alignments that did not fit exactly with our
region of interest were removed. Sequences were pre-clustered
and chimeric sequences were identified and removed, then
taxonomically classified using RDP (ribosomal database project).
Sequences classified as chloroplasts, mitochondria, archaea, and
eukaryote were eliminated. The distances between sequences
were calculated with a distance cut-off of 0.03. After creating
the distance matrix, sequences with >97% similarity were
clustered into operational taxonomic units (OTUs). These OTUs
were filtered and only those that had more than 0.1% relative
abundance and were in at least two samples were conserved.
Each OTU was assigned to a taxonomic classification. OTUs
were classified into the last taxonomic rank possible, with
genus being the furthest rank allowed by the method used.
Rarefaction curves, diversity and richness indexes and distances
between samples were calculated and plotted using RStudio
(version 1.0.143). Diversity was quantified using the Bray–Curtis
dissimilarity test and plotted using non-metric multidimensional
scaling (NMDS). Beta diversity (Shannon’s, Simpson’s, and
Inverse Simpson’s index) was calculated to analyze differences in
diversity between samples.
RESULTS
HFD Determines the Spectrum of Body
Weight Before and After Infection
The animals’ weight was recorded weekly throughout the study.
HFD was found to significantly increase body weight at 2 weeks
after starting the diet. Before Mtb challenge there was a clear
difference in the slope of the body weight increase between ND
and HFD (Figures 1A–F; Table S1; Figure S1). However, this
difference in the growth slope disappeared suddenly after the
challenge for both SI (Figures 1B,C) and MCI (Figures 1E,F),
with HFD exhibiting a sudden deceleration. BCG vaccination
significantly increased body weight in the HFD group just 6
weeks after starting the diet (Figures 1G–L; Figure S1). Animals
FIGURE 2 | Bacillary load progression at different end time points (w3, w4, and w16) are shown as log CFUs/ml. Each panel compares sham and BCG vaccinated
groups: ND and SI (A), ND and MCI (B), HFD and SI (C), HFD and MCI (D). Box and whiskers plots show the minimum, first quartile, median, third quartile and
maximum values. *p < 0.05, **p < 0.01, ***p < 0.001; Mann–Whitney test.
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also showed glucose intolerance and increased cholesterol and
HDL (Figure S2).
BCG Generates Lower Protection in Mice
Fed With HFD in Terms of BL in Lung
Tissue
The BL in lungs was evaluated at weeks 3, 4, and 16 p.i. No
statistically significant differences were found in terms of BL
when comparing diets, although HFD-BCG animals tended to
have higher medians (Figure S3). The type of challenge is a
determinant factor in BL, and was found to be higher in almost
all MCI groups (Figure S4).
As expected, BCG decreased BL by ∼1 log in the groups fed
with ND. This effect was maintained over time (Figures 2A,B).
This improvement was not observed inHFD groups for either the
SI orMCI challenge (Figures 2C,D). It should be noted, however,
that BCG vaccination was administered at the same time as HFD,
before having differences in weight between groups.
Early Infiltration Induced by BCG Does Not
Preclude a Long-Term Reduction in
Pathology Under HFD
Analysis of the histometry revealed different trends in the acute
(weeks 3 and 4) and chronic (week 16) phases of infection
(Figure 3).
In the early stages of infection, and after SI, BCG-vaccinated
animals exhibited less infiltration than sham-vaccinated animals
if fed with ND. However, the opposite was observed in HFD-
fed animals. In contrast, under MCI and ND conditions,
vaccination resulted in larger damaged areas when compared
to control animals. Under MCI and HFD conditions, although
vaccinated mice exhibited more infiltration, this difference was
not statistically significant as the sham group also presented a
large damaged area. In the chronic phase, BCG induced less
infiltration than sham-vaccinated mice under all conditions.
Lesions were classified as proliferative or exudative depending
on their quality. Exudative lesions were present in all sham
groups and were predominant after SI. Most of the lesions
in BCG-vaccinated animals were proliferative, with exudative
lesions being present only in ND-MCI mice. Amongst the sham
groups, HFD exhibited a higher percentage of exudative lesions
than ND (Figure 4). Given the absence of exudative lesions in the
acute phase, this measurement was only performed at week 16.
Cytokine Profile Analysis
Pro-inflammatory cytokines (IFN-γ, IL-2, IL-17, IL-12, IL-6,
and TNF-α), neutrophil recruitment chemokines (CXCL1 and
CXCL5) and anti-inflammatory cytokines (IL-10 and TGF-β)
were analyzed at week 4 p.i. in lung homogenates.
Table 3 shows the p-value summary of the three-way ANOVA
results. Infection was the factor responsible for the largest
variation between cytokines and chemokines (significant in all
except IL-2 and TGF-β). Similarly, IL-2 and IL-12 levels were
significantly affected by BCG vaccination. Thus, the two dietary
conditions alone had no significant effect on the cytokine profile.
FIGURE 3 | Progression of lung disease at different end time points (w3, w4, and w16) is shown as the percentage of damaged area. Each panel compares sham
and BCG vaccinated groups: ND and SI (A), ND and MCI (B), HFD and SI (C), HFD and MCI (D). Bar plots show median with range. *p < 0.05; Mann–Whitney test.
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FIGURE 4 | Quality of the lesions found at week 16 post-infection. The tissue sections show a proliferative (A) and an exudative (B) lesion stained with H/E. (C)
Relative percentage of exudative lesions at week 16. Black bars represent ND groups while red bars represent HFD groups. Hatched bars in each type of diet
represent vaccination Bar plots show median with range. Asterisk indicates differences between vaccination and infection in each diet; hashtag indicates differences
between diets. *p < 0.05, #p < 0.05; Mann–Whitney test.
TABLE 3 | P-value summary of three-way ANOVA from cytokines quantified in lungs (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).
Source of variation IFN-γ IL-2 IL-6 IL-10 IL-12 CXCL5 IL-17 CXCL1 TNF-α TGF-β
Infection **** ns **** ** **** * **** **** **** ns
Diet ns ns ns ns ns ns ns ns ns ns
BCG ns * ns ns * ns ns ns ns ns
Infection × Diet *** ns ns ns ns ** * * ** ns
Infection × BCG ** ns ns ns ns ns ** * ns ns
Diet × BCG * **** ns ns ns ns ns * ** ns
Infection × Diet × BCG ns ** ns ns ns ns ns ns ns ns
Some of the cytokines analyzed presented an interaction between
different factors. For more detailed information, each individual
value is illustrated in Figure S5. Briefly, pro-inflammatory
cytokines were present in higher concentrations in MCI animals.
In the case of IFN-γ, TNF-α, and IL-17, this increase was higher
in mice fed with HFD. In fact, among SI, ND mice had higher
levels of these immune mediators, with the opposite being found
for MCI. The same pattern was observed for CXCL1 and CXCL5.
The levels of anti-inflammatory IL-10 or TGF-β did not differ
significantly between the experimental groups.
A PCA was performed for all inflammatory mediators
(Figure 5). The first two components explain 71.51% of the
variation among samples, with the main contributions to
PC1 coming from CXCL1, IFN-γ, TNF-α, IL-17, and IL-6.
PC2, in contrast, is mostly explained by CXCL5 and TGF-
β. The unvaccinated HFD-MCI animals presented higher PC1
values, whereas HFD-SI animals had higher levels of PC2. As
concluded from the three-way ANOVA analysis, the type of
infection was the factor with the greatest influence on the inter-
sample variation.
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FIGURE 5 | Principal component analysis of inflammatory mediators. (A) Representation of animals according to experimental groups with 95% confidence ellipses.
(B) Samples colored by type of infection.
BCG Vaccination Does Not Increase
Survival Under HFD, Whereas NI Does
Differences in survival rates were analyzed using the Log-rank
test (Figure 6). Irrespective of their vaccination status, MCI mice
had lower survival rates than their SI counterparts, and HFD
always presented a lower median survival time (MST). BCG was
able to significantly increase survival rates irrespective of the
type of challenge under ND (MST from 28 to 34 weeks for SI
and MST from 19 to 24 weeks for MCI) but not under HFD
feeding. Interestingly, NI induced in animals following antibiotic
treatment after SI, until no detectable CFU was achieved, was
protective in HFD but not in ND (Figure 7).
HFD-Induced Obesity and Chemotherapy
Reduce Gut Microbiota Diversity
The gut microbiota studies were performed at weeks 4 and
16 post-infection, corresponding to weeks 16 and 28 from the
beginning of the diet. In our study, OTUs can be considered as
the species found in fecal samples. Given the same number of
reads sequenced, a smaller number of OTUs were found in HFD
samples at both time points (Figures 8A,B), thus suggesting a
lower microbial diversity.
We then assessed the dissimilarity between both diets in
terms of microbiota composition using an NMDS plot and
the Bray–Curtis dissimilarity index. Samples were grouped
according to the type of diet, showing that microbiota
composition differs substantially between diet conditions
(Figure 8C). Other comparisons were performed to evaluate
the influence of BCG vaccination and infection dose on
microbiota composition. This analysis was performed
separately for the ND and HFD groups, showing no significant
differences (Figure S6).
Once the dissimilarity between diets had been confirmed,
Shannon, Simpson, and Inverse Simpson indexes were used
to demonstrate the existence of real differences in microbiota
diversity between the different nutritional statuses. These indexes
showed that ND mice had a statistically significantly higher
diversity than HFD groups (Figure 8D).
The relative abundance of Firmicutes and Bacteroidetes phyla
and the ratio between them were analyzed at both time points,
namely week 16 (Figures 9A,G) and week 28 (Figures 10A,G).
This analysis showed an inverse correlation between the relative
abundance of Bacteroidetes and the animals’ weight, with the
F/B ratio being higher in HFD mice due to the reduction
in Bacteroidetes.
The detailed gut microbiota composition results are shown
in Figure 9 (week 16) and Figure 10 (week 28). Analysis
of the most abundant families showed a significant increase
in Ruminococcaceae and Rikenellaceae, and a reduction in
Porphyromonadaceae with HFD at week 28. Among the genera
from the Firmicutes phylum, mice fed with HFD showed a higher
abundance of Acetatifactor, Anaerotruncus, Clostridium XIVa,
and Oscillibacter at week 28. In contrast, analysis of genera from
the Bacteroidetes phylum showed that HFD mice had a lower
abundance of Alistipes at week 16 than ND, whereas the opposite
was the case at week 28. The levels of the Barnesiella genus are
markedly higher in ND-fed animals at all time points, whereas
Parasuterella (Proteobacteria) is higher in HFD. It is interesting
to note the predominance of the Akkermansia genus at both time
points, and the appearance ofMucispirillum at the last time point,
in HFD-fed mice.
The effect of chemotherapy used to induce NI was also
assessed on gut microbiota (Figure 11). Results indicated that
chemotherapy decreased the F/B ratio in ND due to both
a decreased abundance of Firmicutes and increased levels of
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FIGURE 6 | Evolution of survival after Mtb infection for the first experiment. Each panel compares sham and BCG vaccinated groups: ND and SI (A), ND and MCI (B),
HFD and SI (C), HFD and MCI (D). Median survival times and p-values are indicated in each panel. Log-rank test.
Bacteroidetes. Interestingly, chemotherapy showed the same
trend for HFD, although the differences were not statistically
significant. In the Firmicutes phylum, Lachnospiraceae and
Ruminococcaceae were reduced with chemotherapy in both
diets, whereas for Bacteroidetes, the Porphyromonadaceae family
increased with chemotherapy. Finally, the genus Akkermansia
was substantially increased with chemotherapy in ND.
DISCUSSION
To the best of our knowledge, this is the first time that diet-
induced obesity has been studied in an experimental TB model.
We have chosen to test the impact of anHFD as obesity inducer as
this is the most robust and best characterized model for inducing
metabolic syndrome and glucose intolerance, which are the main
factors leading to DM2 (14). Although our model was able to
induce a marked increase in body weight, we did not observe
a constant hyperglycemia and animals had no need for insulin
treatment. Indeed, this is the current situation for millions of
citizens with this syndrome who will go on to develop DM2 (25).
These variables are introduced in the context of the
C3HeB/FeJ mouse, a unique strain that is able to reproducethe
spectrum of human lesions and is considered to best reflect
the progression from infection to disease (26). This progression
differs from the general tolerance towardMtb infection shown by
inbred mice, which only develop proliferative lesions (27, 28).
In view of recent data, our model is more complex than we
initially thought. Dalby et al. (29) have demonstrated that refined
diets reduce gut microbiota diversity and increase the F/B ratio
irrespective of obesity or dietary fat. They showed that a refined
low fat diet is also able to induce dysbiosis, with no link to obesity
or hyperglycemia. In any case, a high F/B ratio favors glucose
intolerance and is thus linked to an impaired immune response
(14). As such, we have two independent factors that can explain
the increased progression toward TB. First, although metabolic
syndrome and DM2-related obesity, which are clearly linked to
an immune dysfunction, have been observed in other models,
this is not the case in ours. Pre-feeding with HFD for 8 weeks in
CD-1 mice reduced the lethality of Trypanosoma cruzi infection
by 35% (7). Secondly, dysbiosis and an increase in the F/B ratio.
This has also been linked to a decreased resistance to disease in
a study comparing wild mice with lab mice (30). On the other
hand,Mtb infection has consistently been shown to be linked to a
reduction in gut microbiota diversity (15, 17). Our data show that
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FIGURE 7 | Evolution of survival after Mtb infection for the second experiment.
Each panel compares sham and NI groups: ND (A) and HFD (B). Median
survival times and p-values are indicated in each panel. Log-rank test.
HFD aggravates this tendency, thus resulting in a lower survival
in animals fed with HFD.
Although there were no differences in BL between the diets,
BCG only had a positive effect in ND mice, thus revealing
a diminished protective capacity under HFD conditions. To
the best of our knowledge, and with the exception of some
experiments with a Beijing strain challenge (31), this is the
first time that no protective effect has been seen upon BCG
vaccination in mice in terms of BL reduction. However, these
strains are related to the induction of a different pattern of
immune response after triggering an IFN type I response (32),
therefore further studies are required to determine whether HFD
also induces such a response.
Histometry studies shortly after the SI challenge showed an
unusual reaction for the HFD group as these mice exhibit a
stronger reaction after vaccination with BCG than with sham,
in contrast to what occurs in ND animals. Even when this is
not maintained throughout the chronic phase, it seems to be
indicative of a delayed immune response. Moreover, MCI mice
(both BCG and sham vaccinated) exhibit a stronger infiltration
at all the time points studied, although a higher percentage of
damaged area at week 3 after BCG vaccination in ND reflects a
better immune response due to the vaccination. This different
reaction in HFD correlates with the immune impairment of the
response against TB linked to obesity and DM2, as seen above,
although this chronic increase in the pro-inflammatory response
does not result in the expected clear histological phenotype in
terms of increasing the number of exudative lesions. This is
in accordance with the intensity of the risk factor shown by
DM2 (around ×3), which is much lower than the risk factor for
immunosuppression by anti-TNF or AIDS (around×100), where
a clear phenotype can be seen.
As described by several authors, aerosol infection is
able to induce two kinds of lesions in this model, namely
proliferative lesions, which are characterized by a slow
progression and spreading via infected foamy macrophages,
and exudative lesions, in which neutrophils accumulate at
the periphery, thereby fueling the extracellular bacillary
growth that finally results in large-scale central necrosis
(20, 26, 33, 34). Surprisingly, our analysis of the quality of
the lesions revealed larger exudative regions in SI animals
than those MCI infected. As we are currently unable to
explain this phenomenon, further studies in this regard
are required.
The pulmonary cytokine profile showed that, for SI animals,
there is a more pro-inflammatory profile in ND than in HFD
fed mice, irrespective of vaccination status, thus confirming the
delay in the onset of the immune response in HFD seen in
the histometry. However, this pattern reverts when animals are
challenged with MCI, thus receiving far higher bacillary counts.
This strong pro-inflammatory response in HFD mice has no
advantage in terms of BL reduction, a fact than may reflect a
higher basal pro-inflammatorymilieu. This could also explain the
pathology results.
Data published by Rosshart et al. (30) regarding the ability
of natural microbiota, in terms of diversity and F/B ratio, to
benefit a balanced systemic and local inflammatory response,
which in this case would have more similarities to ND than
HFD fed mice, merit more in-depth studies, including mice
fed with refined low fat diets (29). This is an important issue
given the recent paper by Maji et al. (19), which found a
higher diversity of the intestinal microbiome in TB patients
compared with controls, thus resulting in a higher presence
of short-chain fatty acids. These authors claim that these
products, especially butyrate, have a strong anti-inflammatory
effect after stimulating Tregs in the gut, thus promoting
IL-10 production and facilitating a chronic infection, which
contradicts the concept of Rosshart et al. (30). Indeed, as
highlighted by the authors, there is an important confusing
factor in that study, namely the BMI, which is significantly
lower in TB patients. It is well-known that a low BMI
has a major impact in TB and other diseases by inducing
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FIGURE 8 | Analysis of the microbiota diversity based on 16S rRNA sequencing. In each panel the ND group is colored in black and the HFD group in red. Rarefaction
curves at week 16 (A) and week 28 (B) after starting the different diets are represented. (C) NMDS ordination in samples following different diets. (D) Shannon,
Simpson and inverse Simpson diversity indexes. **p < 0.01, ***p < 0.001; Mann–Whitney test.
a global immune dysfunction as a consequence of protein-
energy undernutrition, which impairs T-lymphocyte-mediated
responses (35).
In our model, HFD caused gut microbiota dysbiosis, thus
inducing a pro-inflammatory milieu that limits the bacteriome
diversity. This caused an increase in the F/B ratio. These are
the most important phyla in humans, with Bacteroidetes being
reduced due to obesity and subsequently being restored, along
with a reduction in Firmicutes, after losing body weight on
a diet (36). The question now arises as to how this dysbiosis
influences the fate of TB progression. The recent study by
Rosshart et al. (30) links a high diversity and low F/B ratio to the
promotion of host fitness and limited inflammatory responses
against influenza A and colorectal tumorigenesis. This is
coherent with our findings, which also point to a sort of “neutral
effect” caused by the abundance of Porphyromonadaceae
family, and specifically Barnesiella, found under
ND conditions.
In our system, analysis of the microbiota showed differences
with previous data obtained in mice fed with HFD. These
differences are probably related to both Mtb infection and the
time of feeding, as in our case the analysis was done after 16 and
28 weeks of feeding, which is far longer than the usual 8–12 weeks
reported previously (14, 29).
With regard to the Firmicutes phyla, ND presented lower
levels (at week 28) of Ruminococcaceae, which is related to the
production of short-chain fatty acids (37), thus triggering an anti-
inflammatory response. It is interesting to note that the epitope
expressed on the flagellin of the Lachnospiraceae, which becomes
the most important Firmicutes family in both diets, is a potent
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FIGURE 9 | Taxonomic composition of the intestinal microbiota based on 16S rRNA sequencing at week 16 after starting both diets. Analysis of the relative
abundance of the most abundant phylum (A), class (B), order (C), family (D), and genus (E) in ND vs. HFD. (F) Bar plot representation of the OTUs of each sample
according the taxonomic classification. (G) Regression plot of Firmicutes and Bacteroidetes phyla against animal weight and analysis of the F/B ratio in ND and HFD.
*p < 0.05, **p < 0.01, ***p < 0.001; Mann–Whitney test.
inducer of Tregs and TGF-β in dendritic cells in mice (38, 39).
Lachnospiraceae increased significantly in mice under stress.
In this study, stress caused an increase in systemic corticoid,
IFN-γ and IL-17 levels, as well as mucosal injury (40). This is
coherent with the stress induced by TB infection regardless of
diet. At a genus level, and although they only represented a small
percentage of the total microbiota, HFD presented an increase
in Clostridium XIVa, which promotes the expansion of Tregs
(39), as well as Anaerotruncus and Acetatifactor, which have been
related to arthritis progression in mice, thus suggesting a pro-
inflammatory response (41). Interestingly, we have also detected
a total absence of the Lactobacillaceae family in C3HeB/FeJ
mice. This is a relevant factor as, according to Winglee et al.
(15), this is the predominant family (around 50% of relative
abundance) in Mtb-infected C57BL/6 mice. Curiously, recent
data from Namasyvayam et al. (16) in Mtb-infected C57BL/6J-
CD45a(Ly5a) mice also found this family, but in a very low
relative abundance (around 3%). As such, this may be a critical
point in the gut microbiome of C3HeB/FeJ as it may be
determinant for triggering the strong inflammatory response that
causes exudative lesions. Lactobacillaceae has also been related
to a decrease in the inflammatory response, and thus immune
balance, although this proposal remains controversial as it was
reported in the context of inflammatory bowel disease (37).
The most remarkable differences caused by diet were seen
in the Bacteroidetes phylum. Thus, HFD-fed mice showed
significantly lower levels of the Barnesiella genus at both time
points, along with an increase in the Alistipes genus with
time. These changes may be crucial in the different evolution
experimented by both groups. Thus, the most abundant family
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FIGURE 10 | Taxonomic composition of the intestinal microbiota based on 16S rRNA sequencing at week 28 after starting both diets. Analysis of the relative
abundance of the most abundant phylum (A), class (B), order (C), family (D), and genus (E) in ND vs. HFD. (F) Bar plot representation of the OTUs of each sample
according the taxonomic classification. (G) Regression plot of Firmicutes and Bacteroidetes phyla against animal weight and analysis of the F/B ratio in ND and HFD.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; Mann–Whitney test.
in both diets is Porphyromonadaceae, which is decreased under
HFD conditions. Porphyromonadaceae is increased in mice fed
with a high-protein/low carbohydrate diet (42) and decreased in
mice fed with omega-6-polyunsaturated fatty acids (43). This has
been related with the dysbiosis shown in patients with ankylosing
spondylitis, a heritable immune-mediated arthropathy (44). The
Barnesiella genus has proved useful for reducing the colonization
of Enterococcus in a “neutral way” as it is not thought to be
associated with immune development or inflammatory diseases
in the intestine (45). In contrast, Alistipes is the most significant
over-represented taxon related to frailty in the elderly (46) and
is found to be increased under HFD conditions (47). Overall,
it appears that colonization with the Porphyromonadaceae
family, and in particular the Barnesiella genus, may have a
positive impact on reducing the pro-inflammatory milieu in
the gut.
With regard to Proteobacteria, HFD caused a sustained
increase in the genus Parasutterella, which is precisely the
opposite to what was found in C57BL/6 (47). Additional
microbiome studies in humans and rats have associated
an increased abundance of Parasutterella with dysbiosis
in the gut, with this genus being increased in the
submucosa of individuals with Crohn’s disease (48) and
in rats with hypertriglyceridemia-related acute necrotizing
pancreatitis (49).
Finally, HFD mice had a higher relative abundance of
Mucispirillum and Akkermansia genera. Unlike the majority
of commensal bacteria, Akkermansia and Mucispirillum evade
T-independent IgA and elicit a T-dependent response (50). In
contrast to our observations, the abundance of Akkermansia
muciniphila is decreased during obesity and diabetes, and
administration thereof can counteract the development of
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FIGURE 11 | Taxonomic composition of the intestinal microbiota based on 16S rRNA sequencing between different diets and under chemotherapy. Analysis of the
relative abundance of the most abundant phylum (A), class (B), order (C), family (D), and genus (E). (F) Bar plot representation of the OTUs of each sample according
the taxonomic classification. (G) Analysis of the F/B ratio. *p < 0.05, **p < 0.01; Mann–Whitney test.
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HFD-induced obesity and gut barrier dysfunction. Its effect
is increased when given inactivated by pasteurization, a
mechanism linked to the increase in mucus production
(51). Mucispirillum schaedleri has been reported to be
elevated in abundance during intestinal inflammation in
mouse models, and has been described as a mucus-associated
bacterium adapted to the oxidative burst that occurs during
inflammation (52).
Another unknown was the effect caused by chemotherapy
after aerosol infection. A more significant impact was found
for the gut microbiota of ND mice, which could give a clue
as to why natural infection was less effective in this group.
Animals fed with ND presented a drastic reduction in the
F/B ratio with chemotherapy. This is mainly explained by a
reduction in Lachnospiraceae for Firmicutes and an increase
in Porphyromonadaceae for Bacteroidetes, thus increasing
the “neutral” effect of the microbiota. Chemotherapy also
markedly promoted the presence of the Akkermansia genus
in ND, thus increasing T-cell stimulation. In view of these
results, we can hypothesize that induction of a protective
effect by natural infection might require a certain anti-
inflammatory effect. This is coherent with recent findings
suggesting that excess effector T-cell stimulation might be
deleterious to a protective immune response (53, 54). In
HFD mice, in contrast, chemotherapy did not impact the
abundance of Firmicutes, with the increase in several Clostridium
appearing to “compensate” the loss of Ruminococcaceae and
Lachnospiraceae. It also failed to impact the abundance of
Bacteroidetes and triggered the presence of Enterobacteriaceae,
which is difficult to analyze since it did not affect the levels
of Akkermansia.
Overall, our findings show that HFD accelerates the
progression toward active TB. Although we have not been able
to discern the exact mechanism of action, our results point to
a dysregulation in the ability to react to Mtb infection, which
appears to slow the appearance of immunity in the early stages
post-challenge. HFD-fed animals show a reduced ability to detect
low dose infection, while reacting excessively to a high dose, thus
leading to a reduced survival. This may be related to the HFD
causing early DM2, as supported by a dysbiosis in the intestinal
microbiota that promotes an intolerance to glucose. Interestingly,
even when natural immunity induced by Mtb followed by
chemotherapy is able to induce protection, BCG vaccination
protection is reduced in terms of BL and survival. This finding
highlights the need to further explore the mechanisms of this
difference in order to design a better vaccine that can protect
against this rapidly growing comorbidity, which is starting to
hamper current efforts to control TB.
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